Cargando…
AL Amyloidosis and Multiple Myeloma: A Complex Scenario in Which Cardiac Involvement Remains the Key Prognostic Factor
Monoclonal gammopathies (MGs) are a wide range of diseases that may evolve or progress over time. Comorbidity plays a critical role in this setting. The co-occurrence of two MGs is not a rare event. The evidence on the association of systemic light chain (AL) amyloidosis and multiple myeloma (MM) is...
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10382070/ https://www.ncbi.nlm.nih.gov/pubmed/37511893 http://dx.doi.org/10.3390/life13071518 |
_version_ | 1785080601453264896 |
---|---|
author | Ríos-Tamayo, Rafael Krsnik, Isabel Gómez-Bueno, Manuel Garcia-Pavia, Pablo Segovia-Cubero, Javier Huerta, Ana Salas, Clara Silvestre, Ramona Ángeles Sánchez, Amelia Manso, Marta Delgado, Laura Lahuerta, Juan José Martínez-López, Joaquín Duarte, Rafael F. |
author_facet | Ríos-Tamayo, Rafael Krsnik, Isabel Gómez-Bueno, Manuel Garcia-Pavia, Pablo Segovia-Cubero, Javier Huerta, Ana Salas, Clara Silvestre, Ramona Ángeles Sánchez, Amelia Manso, Marta Delgado, Laura Lahuerta, Juan José Martínez-López, Joaquín Duarte, Rafael F. |
author_sort | Ríos-Tamayo, Rafael |
collection | PubMed |
description | Monoclonal gammopathies (MGs) are a wide range of diseases that may evolve or progress over time. Comorbidity plays a critical role in this setting. The co-occurrence of two MGs is not a rare event. The evidence on the association of systemic light chain (AL) amyloidosis and multiple myeloma (MM) is scarce and controversial. Herein we aim to address this topic in a large series of patients of a referral center. All consecutive AL amyloidosis patients treated at our center from January 2005 to April 2023 were prospectively enrolled in a clinical and epidemiological registry. 141 patients diagnosed with AL amyloidosis were included, of which 7 (5%) had localized whereas 134 presented with systemic disease. The heart was the most frequently affected organ (90.3%). 25 patients (18.7%) fulfilled the IMWG diagnostic criteria of MM (AL/MM). Time-dependent association between AL and MM showed that the synchronous pattern is more frequent than the appearance of a second primary malignancy. The diagnostic delay was six months (m). Patients with AL/MM had a poorer median overall survival (OS) than AL-only patients (35.5 m, CI 95% 0–88.9, vs. 52.6 m, CI 95% 16.7–88.5), but this difference was not statistically significant. The prognosis in AL is dominated by the heart involvement, which is massive in this series. In our Cox regression model, only three prognostic variables remain as independent prognostic factors: age, N-terminal pro-brain natriuretic peptide (≥8500 ng/L), and undergoing an autologous stem cell transplant, whereas left ventricular ejection fraction shows a marginal effect. More and large studies focusing on the AL/MM association are needed to uncover the characteristics and prognostic impact of this association. |
format | Online Article Text |
id | pubmed-10382070 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-103820702023-07-29 AL Amyloidosis and Multiple Myeloma: A Complex Scenario in Which Cardiac Involvement Remains the Key Prognostic Factor Ríos-Tamayo, Rafael Krsnik, Isabel Gómez-Bueno, Manuel Garcia-Pavia, Pablo Segovia-Cubero, Javier Huerta, Ana Salas, Clara Silvestre, Ramona Ángeles Sánchez, Amelia Manso, Marta Delgado, Laura Lahuerta, Juan José Martínez-López, Joaquín Duarte, Rafael F. Life (Basel) Article Monoclonal gammopathies (MGs) are a wide range of diseases that may evolve or progress over time. Comorbidity plays a critical role in this setting. The co-occurrence of two MGs is not a rare event. The evidence on the association of systemic light chain (AL) amyloidosis and multiple myeloma (MM) is scarce and controversial. Herein we aim to address this topic in a large series of patients of a referral center. All consecutive AL amyloidosis patients treated at our center from January 2005 to April 2023 were prospectively enrolled in a clinical and epidemiological registry. 141 patients diagnosed with AL amyloidosis were included, of which 7 (5%) had localized whereas 134 presented with systemic disease. The heart was the most frequently affected organ (90.3%). 25 patients (18.7%) fulfilled the IMWG diagnostic criteria of MM (AL/MM). Time-dependent association between AL and MM showed that the synchronous pattern is more frequent than the appearance of a second primary malignancy. The diagnostic delay was six months (m). Patients with AL/MM had a poorer median overall survival (OS) than AL-only patients (35.5 m, CI 95% 0–88.9, vs. 52.6 m, CI 95% 16.7–88.5), but this difference was not statistically significant. The prognosis in AL is dominated by the heart involvement, which is massive in this series. In our Cox regression model, only three prognostic variables remain as independent prognostic factors: age, N-terminal pro-brain natriuretic peptide (≥8500 ng/L), and undergoing an autologous stem cell transplant, whereas left ventricular ejection fraction shows a marginal effect. More and large studies focusing on the AL/MM association are needed to uncover the characteristics and prognostic impact of this association. MDPI 2023-07-06 /pmc/articles/PMC10382070/ /pubmed/37511893 http://dx.doi.org/10.3390/life13071518 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Ríos-Tamayo, Rafael Krsnik, Isabel Gómez-Bueno, Manuel Garcia-Pavia, Pablo Segovia-Cubero, Javier Huerta, Ana Salas, Clara Silvestre, Ramona Ángeles Sánchez, Amelia Manso, Marta Delgado, Laura Lahuerta, Juan José Martínez-López, Joaquín Duarte, Rafael F. AL Amyloidosis and Multiple Myeloma: A Complex Scenario in Which Cardiac Involvement Remains the Key Prognostic Factor |
title | AL Amyloidosis and Multiple Myeloma: A Complex Scenario in Which Cardiac Involvement Remains the Key Prognostic Factor |
title_full | AL Amyloidosis and Multiple Myeloma: A Complex Scenario in Which Cardiac Involvement Remains the Key Prognostic Factor |
title_fullStr | AL Amyloidosis and Multiple Myeloma: A Complex Scenario in Which Cardiac Involvement Remains the Key Prognostic Factor |
title_full_unstemmed | AL Amyloidosis and Multiple Myeloma: A Complex Scenario in Which Cardiac Involvement Remains the Key Prognostic Factor |
title_short | AL Amyloidosis and Multiple Myeloma: A Complex Scenario in Which Cardiac Involvement Remains the Key Prognostic Factor |
title_sort | al amyloidosis and multiple myeloma: a complex scenario in which cardiac involvement remains the key prognostic factor |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10382070/ https://www.ncbi.nlm.nih.gov/pubmed/37511893 http://dx.doi.org/10.3390/life13071518 |
work_keys_str_mv | AT riostamayorafael alamyloidosisandmultiplemyelomaacomplexscenarioinwhichcardiacinvolvementremainsthekeyprognosticfactor AT krsnikisabel alamyloidosisandmultiplemyelomaacomplexscenarioinwhichcardiacinvolvementremainsthekeyprognosticfactor AT gomezbuenomanuel alamyloidosisandmultiplemyelomaacomplexscenarioinwhichcardiacinvolvementremainsthekeyprognosticfactor AT garciapaviapablo alamyloidosisandmultiplemyelomaacomplexscenarioinwhichcardiacinvolvementremainsthekeyprognosticfactor AT segoviacuberojavier alamyloidosisandmultiplemyelomaacomplexscenarioinwhichcardiacinvolvementremainsthekeyprognosticfactor AT huertaana alamyloidosisandmultiplemyelomaacomplexscenarioinwhichcardiacinvolvementremainsthekeyprognosticfactor AT salasclara alamyloidosisandmultiplemyelomaacomplexscenarioinwhichcardiacinvolvementremainsthekeyprognosticfactor AT silvestreramonaangeles alamyloidosisandmultiplemyelomaacomplexscenarioinwhichcardiacinvolvementremainsthekeyprognosticfactor AT sanchezamelia alamyloidosisandmultiplemyelomaacomplexscenarioinwhichcardiacinvolvementremainsthekeyprognosticfactor AT mansomarta alamyloidosisandmultiplemyelomaacomplexscenarioinwhichcardiacinvolvementremainsthekeyprognosticfactor AT delgadolaura alamyloidosisandmultiplemyelomaacomplexscenarioinwhichcardiacinvolvementremainsthekeyprognosticfactor AT lahuertajuanjose alamyloidosisandmultiplemyelomaacomplexscenarioinwhichcardiacinvolvementremainsthekeyprognosticfactor AT martinezlopezjoaquin alamyloidosisandmultiplemyelomaacomplexscenarioinwhichcardiacinvolvementremainsthekeyprognosticfactor AT duarterafaelf alamyloidosisandmultiplemyelomaacomplexscenarioinwhichcardiacinvolvementremainsthekeyprognosticfactor |